Form D Explorer

Inspect source fieldsReport a record issue

Form D — Tango Therapeutics, Inc.

0001819133-25-000003 · filed Oct 28, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$14,999,995
Reported amount sold
$14,999,995
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Tango Therapeutics, Inc.
CIK
1819133
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
201 BROOKLINE AVENUE
BOSTON, Massachusetts 02215
Phone
(857) 320-4900

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗